Pfizer Receives Inquiry From SEC Bribery Unit
Pfizer disclosed in a new financial statement that it received an inquiry from the SEC's foreign-bribery unit regarding its operations in China.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.